A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest evidence yet that a shorter ...
"Anyone with lungs can get lung cancer, yet lung cancer continues to receive less research funding compared to other cancers.
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...
Although overall cancer mortality rates are declining for Black patients, they continue to have higher mortality rates than White patients for some cancers.
Zydus Lifesciences Ltd has received USFDA approval to manufacture a generic version of Apalutamide tablets for prostate cancer treatment. The 60 mg tablets will be produced in Ahmedabad, addressing a ...
Researchers evaluated billing for early palliative care among Medicare beneficiaries who were newly diagnosed with 1 of 6 common distant-stage cancers.
14h
Vietnam Investment Review on MSNIlluccix® Approved for Prostate Cancer Imaging in Brazil First Marketing Authorization in Latin AmericaMELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...
Free prostate cancer screenings will be available at the Pike County Health Department at 900 S. Franklin Drive from 10 a.m. until 2 p.m. on March 22. Prostate Cancer is the second leading cause of ...
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...
Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).
Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...
A former Dunfermline High School pupil has been celebrated for her outstanding research in the field of cancer studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results